- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT01815671
Evaluate the Safety and Diagnostic Advantages of Tilt Down Verses Standard Horizontal Colonoscopy Positioning (CTDTTIE)
The Effect of Body Positioning for Colonoscopy in Women: Randomized, Study of Left Lateral Tilt Down Versus Left Lateral Horizontal Positioning
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
This was a prospective, randomized study. Subjects who provide informed consent and present to the offices of Specialists in Gastroenterology for colonoscopy will be randomized in a 1:1 distribution to either left lateral tilt down versus left lateral horizontal positioning to initiate colonoscopy.
Demographic data as well as routine information regarding the colonoscopy was filled out during or at the end of each procedure. In addition, the following parameters were assessed, and compared between groups:
- Occurrence of complications related or possibly related to the colonoscopy procedure
- Scope insertion time
- Pain during and after the procedure
The subjects' participation was limited to the duration of the colonoscopy, which is typically less than 60 min and a follow up by telephone 24 hours later to assess the occurrence of complications.
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
Missouri
-
St. Louis, Missouri, Forenede Stater, 63141
- Advanced Endoscopy Center
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- ability to understand and sign consent
- women and men with a BMI (body mass index) <35 kg/m2
- age 18 - 90 years
- no liquids by mouth for ≥2 hours
- no solid food for ≥8 hours
Exclusion Criteria:
- inability to provide informed consent
- morbid obesity (BMI ≥35)
- pregnancy
- uncontrolled gastroesophageal reflux disease
- gastroparesis
- scleroderma
- achalasia
- Crohn's disease
- ulcerative colitis
- history of a colon resection
- Parkinson's disease
- brain tumor
- multiple sclerosis
- ischemic optic neuropathy
- glaucoma
- active pulmonary infection
- liquid intake <2 hours
- solid food intake <8 hours prior to the procedure
- intra-procedure findings of a stricture resulting in an incomplete colonoscopy or Boston bowel preparation scores of <6
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Andet: Lateral horizontal body position
Subjects randomized to receive colonoscopy in the lateral horizontal position, This is the standard position.
The other position - tilt down is the intervention
|
colonoscopy in the lateral horizontal position with tilt down
|
|
Andet: Lateral tilt down body position
Subjects randomized to receive colonoscopy in the lateral tilt down position
|
colonoscopy in the lateral horizontal position with tilt down
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Number of Participants Who Experience Adverse Events Which Are Related or Possibly Related to the Colonoscopy Procedure
Tidsramme: 24 hours
|
The number of participants who experience adverse events which are related or possibly related to the colonoscopy procedure will be tallied in each treatment arm.
|
24 hours
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Time to Full Colonoscope Insertion
Tidsramme: 30 minutes
|
30 minutes
|
|
|
Pain Related or Possibly Related to Colonoscopy Procedure
Tidsramme: 24 hours
|
Visual Analogue Scale measured 0-4 with zero being no pain and 4 being most severe pain.
|
24 hours
|
Samarbejdspartnere og efterforskere
Efterforskere
- Ledende efterforsker: Leonard B Weinstock, MD, Specialists in Gastroenterology, LLC
Publikationer og nyttige links
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- BP-1
- Leonard Weinstock, MD (Anden identifikator: Specialists in Gastroenterology)
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
produkt fremstillet i og eksporteret fra U.S.A.
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .